======= CHSY1 ======= == Gene Information == * **Official Symbol**: CHSY1 * **Official Name**: chondroitin sulfate synthase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=22856|22856]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q86X52|Q86X52]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CHSY1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CHSY1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608183|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the chondroitin N-acetylgalactosaminyltransferase family. These enzymes possess dual glucuronyltransferase and galactosaminyltransferase activity and play critical roles in the biosynthesis of chondroitin sulfate, a glycosaminoglycan involved in many biological processes including cell proliferation and morphogenesis. Decreased expression of this gene may play a role in colorectal cancer, and mutations in this gene are a cause of temtamy preaxial brachydactyly syndrome. [provided by RefSeq, Dec 2011]. * **UniProt Summary**: Has both beta-1,3-glucuronic acid and beta-1,4-N- acetylgalactosamine transferase activity. Transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Involved in the negative control of osteogenesis likely through the modulation of NOTCH signaling. {ECO:0000269|PubMed:11514575, ECO:0000269|PubMed:21129727}. |CHGN| |Fringe| |N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity| |glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity| |sulfation| |chondroitin sulfate biosynthetic process| |chondroitin sulfate proteoglycan biosynthetic process| |proximal/distal pattern formation| |positive regulation of smoothened signaling pathway| |chondroitin sulfate metabolic process| |chondrocyte development| |chondroitin sulfate proteoglycan metabolic process| |proteoglycan biosynthetic process| |negative regulation of ossification| |regulation of smoothened signaling pathway| |chondrocyte differentiation| |proteoglycan metabolic process| |Golgi cisterna membrane| |glycosaminoglycan biosynthetic process| |mucopolysaccharide metabolic process| |aminoglycan biosynthetic process| |bone morphogenesis| |glycosaminoglycan metabolic process| |aminoglycan metabolic process| |cartilage development| |sulfur compound biosynthetic process| |regulation of ossification| |bone development| |connective tissue development| |skeletal system morphogenesis| |glycoprotein biosynthetic process| |regionalization| |sulfur compound metabolic process| |glycoprotein metabolic process| |pattern specification process| |skeletal system development| |response to nutrient levels| |response to extracellular stimulus| |carbohydrate derivative biosynthetic process| |Golgi membrane| |animal organ morphogenesis| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |negative regulation of multicellular organismal process| |organonitrogen compound biosynthetic process| |cell development| |positive regulation of signal transduction| |cellular macromolecule biosynthetic process| |small molecule metabolic process| |tissue development| |macromolecule biosynthetic process| |positive regulation of cell communication| |positive regulation of signaling| |extracellular region| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|2.6| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5497 * **Expression level (log2 read counts)**: 6.79 {{:chemogenomics:nalm6 dist.png?nolink |}}